ANAGRELIDE HYDROCHLORIDE

Search structure
Trade Names:
Synonyms:
Status: Approved (1997)
Entry Type: Small molecule
Molecule Category: Salt
UNII: YTM763Y5C8
Parent Compound: ANAGRELIDE

Structure
InChI Key TVWRQCIPWUCNMI-UHFFFAOYSA-N
Smile Cl.O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1
InChI
InChI=1S/C10H7Cl2N3O.ClH/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7;/h1-2H,3-4H2,(H,13,14,16);1H

Physicochemical Descriptors

Property Name Value
Molecular Formula C10H8Cl3N3O
Molecular Weight 292.55
AlogP 1.93
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 0.0
Polar Surface Area 44.7
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 16.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Phosphodiesterase 3 inhibitor
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- - - - 5.284

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

Parent

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Cardiac disorders
15.57
Vascular disorders
13.02
Nervous system disorders
9.66
General disorders and administration site conditions
6.73
Gastrointestinal disorders
6.64
Respiratory, thoracic and mediastinal disorders
5.69
Metabolism and nutrition disorders
5.65
Investigations
4.95
Blood and lymphatic system disorders
4.64
Skin and subcutaneous tissue disorders
3.99
Injury, poisoning and procedural complications
3.7
Infections and infestations
3.27
Musculoskeletal and connective tissue disorders
2.86
Renal and urinary disorders
2.85
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.3

Cross References

Resources Reference
ChEBI 55345
ChEMBL CHEMBL1200759
DrugBank DB00261
FDA SRS YTM763Y5C8
PubChem 57515909
SureChEMBL SCHEMBL318593
CONTENTS